ABP 938 Global P3 Study
Research payments
$800,362
Through program year 2024, $800,362 in research payments was reported against ABP 938 Global P3 Study, across 64 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $39,717 | 4 |
| 2022 | Research | $758,781 | 59 |
| 2020 | Research | $1,864 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Sanford Chen Santa Ana, CA Named on 2 payments
- Rahul Reddy Phoenix, AZ Named on 2 payments
- Curtis Hagedorn Denver, CO Named on 2 payments
- Sean Adrean Fullerton, CA Named on 2 payments
- Scott Friedman Lakeland, FL Named on 2 payments
- David Rabady Albany, NY Named on 2 payments
- Nikolas London San Diego, CA Named on 2 payments
- Erik Kruger Kingston, PA Named on 2 payments
- Zachary Segal South Miami, FL Named on 2 payments
- Prema Abraham Rapid City, SD Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.